# NEPHROCARE (NEPHROCARE)
> Exchange: NSE | Sector:  | ISIN: 

## Price
Current Price: ₹74
Day Change: +0.14%
52W High: ₹0
52W Low: ₹0
Market Cap: ₹0 Cr

## Valuation
P/E: 0
P/B: 0
EPS: ₹0
Book Value: ₹0
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 0%
ROCE: 18.34%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
NEPHROCARE is a listed Indian business company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Unknown
Industry: Unknown
Sub Industry: Unknown

## Business Model
Overview: NEPHROCARE makes money through Core products and services, Customer and channel-led sales, Ancillary operating income in its operating segment. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within its sector.
Source: Derived from stock data
Revenue Streams:
- Core products and services
- Customer and channel-led sales
- Ancillary operating income
Operating Model:
- Converts operating assets, distribution reach, and customer demand into revenue across its chosen markets.
- Scale, margins, working capital, capital allocation, and competitive intensity drive shareholder returns.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-06-08T20:00:07.519Z
Price History Updated: Unknown
Latest Price History Date: Unknown
Technicals Updated: Unknown
Quant Updated: Unknown
Sentiment Updated: Unknown
Financials Status: current
Financials Updated: 2026-05-20T17:58:58.232Z
Financials Last Attempt: 2026-05-20T17:58:58.232Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹46.03 Cr
Operating Profit: ₹3.41 Cr (OPM 7.41%)
Net Profit: ₹3.64 Cr
Tax: ₹1.19 Cr

## Annual P&L History
FY25: Rev ₹46.03Cr | PAT ₹3.64Cr | OPM 7.41%
FY24: Rev ₹27.23Cr | PAT ₹4.41Cr | OPM 21.81%
FY23: Rev ₹17.09Cr | PAT ₹1.94Cr | OPM 16.91%

## Balance Sheet (FY25)
Total Assets: ₹68.28 Cr
Total Liabilities: ₹14.8 Cr
Borrowings: ₹0 Cr
Cash: ₹4.66 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/nephrocare
Disclaimer: For research and education only. Not investment advice.